Credit Suisse’s iKang Healthcare Group, Inc. KANG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-43,080
| Closed | -$878K | – | 4258 |
|
|
2018
Q4 | $878K | Buy |
43,080
+7,563
| +21% | +$135K | ﹤0.01% | 2888 |
|
|
2018
Q3 | $643K | Sell |
35,517
-327,848
| -90% | -$6.32M | ﹤0.01% | 3158 |
|
|
2018
Q2 | $7.43M | Sell |
363,365
-5,782
| -2% | -$117K | 0.01% | 1444 |
|
|
2018
Q1 | $7.37M | Buy |
369,147
+5,545
| +2% | +$93.2K | 0.01% | 1439 |
|
|
2017
Q4 | $5.75M | Buy |
363,602
+7,181
| +2% | +$104K | 0.01% | 1677 |
|
|
2017
Q3 | $4.8M | Buy |
356,421
+24,526
| +7% | +$328K | ﹤0.01% | 1795 |
|
|
2017
Q2 | $4.07M | Sell |
331,895
-20,058
| -6% | -$291K | ﹤0.01% | 1765 |
|
|
2017
Q1 | $5.14M | Sell |
351,953
-52,672
| -13% | -$866K | ﹤0.01% | 1634 |
|
|
2016
Q4 | $7.01M | Buy |
404,625
+127,531
| +46% | +$2.16M | 0.01% | 1423 |
|
|
2016
Q3 | $5.01M | Buy |
277,094
+30,404
| +12% | +$559K | ﹤0.01% | 1653 |
|
|
2016
Q2 | $4.52M | Buy |
246,690
+146,626
| +147% | +$2.95M | 0.01% | 1701 |
|
|
2016
Q1 | $2.19M | Sell |
100,064
-138,953
| -58% | -$2.89M | ﹤0.01% | 2137 |
|
|
2015
Q4 | $4.89M | Sell |
239,017
-5,525
| -2% | -$95.3K | 0.01% | 1596 |
|
|
2015
Q3 | $3.62M | Buy |
244,542
+117,784
| +93% | +$1.91M | ﹤0.01% | 1810 |
|
|
2015
Q2 | $2.45M | Buy |
126,758
+73,794
| +139% | +$1.36M | ﹤0.01% | 2379 |
|
|
2015
Q1 | $859K | Buy |
52,964
+33,397
| +171% | +$557K | ﹤0.01% | 3114 |
|
|
2014
Q4 | $294K | Buy |
+19,567
| New | +$348K | ﹤0.01% | 4067 |
|
Credit Suisse's KANG Position: Q1 2019 in Review
Credit Suisse sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 43,080 shares — an estimated $878K sold.
Credit Suisse first reported a position in KANG in Q4 2014 and held it in 17 quarters. The position peaked at $7.43M in Q2 2018. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.
- Credit Suisse reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
- Credit Suisse sold 43,080 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $878K.
- Credit Suisse first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 17 quarters.
- Credit Suisse's iKang Healthcare Group, Inc. position peaked at $7.43M in Q2 2018.
- 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.
Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.